Sign In
Buy CMPS
$5.33
+0.125 (+2.40%)
At Close: Nov 17, 2025
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
06:30am, Wednesday, 05'th Nov 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
COMPASS Pathways plc (CMPS) Q3 2025 Earnings Call Transcript
11:16am, Tuesday, 04'th Nov 2025
COMPASS Pathways plc ( CMPS ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Stephen Schultz - Senior Vice President of Investor Relations Kabir Nath - CEO & Director Teri Lox
Compass Pathways to expedite launch timing of its experimental depression therapy
06:45am, Tuesday, 04'th Nov 2025
Drug developer Compass Pathways said on Tuesday it is pulling forward the expected launch timing of its experimental psilocybin-based depression therapy by 9 to 12 months.
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression
08:30am, Thursday, 30'th Oct 2025
Collaboration will leverage AI-powered neural analysis and Compass' expertise in psychedelic drug development to advance new therapies for mental health KEARNY, N.J. , Oct. 30, 2025 /PRNewswire/ -- Ne
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
06:30am, Wednesday, 29'th Oct 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025
06:30am, Tuesday, 28'th Oct 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
COMPASS Pathways Plc (CMPS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
02:03pm, Tuesday, 09'th Sep 2025
COMPASS Pathways plc (NASDAQ:CMPS ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:45 AM EDT Company Participants Kabir Nath - CEO & Director Guy Goodwin - Chief Medical
COMPASS Pathways Plc (CMPS) Presents At Cantor Global Healthcare Conference 2025 Transcript
04:56am, Thursday, 04'th Sep 2025
COMPASS Pathways plc (NASDAQ:CMPS ) Cantor Global Healthcare Conference 2025 September 3, 2025 1:35 PM EDT Company Participants Kabir Nath - CEO & Director Guy Goodwin - Chief Medical Officer Steve Le
Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder
06:30am, Tuesday, 02'nd Sep 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Participate in Four Investor Conferences in September
06:30am, Wednesday, 27'th Aug 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA
06:30am, Tuesday, 05'th Aug 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass (CMPS) Q2 Loss Improves 27%
01:16am, Friday, 01'st Aug 2025
Compass (CMPS) Q2 Loss Improves 27%
COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript
10:32am, Thursday, 31'st Jul 2025
COMPASS Pathways plc (NASDAQ:CMPS ) Q2 2025 Earnings Call July 31, 2025 8:00 PM ET Company Participants Guy Goodwin - Chief Medical Officer Kabir Kumar Nath - CEO & Director Lori Englebert - Chief Com
Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights
06:30am, Thursday, 31'st Jul 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
